Influenza Virus Vaccine, H5N1
Influenza Virus Vaccine, H5N1 is an FDA-licensed reference biologic from Sanofi Pasteur Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2007
Reference approved
Reference product
Not listed Influenza Virus Vaccine, H5N1
Sanofi Pasteur Inc.
- Approved
- Apr 17, 2007
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Influenza Virus Vaccine, H5N1, in chronological order.
Reference approval
Approval date of the reference Influenza Virus Vaccine, H5N1 product.
19 yr 5 mo ago
Frequently asked questions
Are there biosimilars approved for Influenza Virus Vaccine, H5N1?
No 351(k) biosimilars or interchangeable biosimilars referencing Influenza Virus Vaccine, H5N1 are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.